Kurse werden geladen...
Prognose
| Kaufen | 0 |
| Halten | 0 |
| Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Why Is Lucira Health (LHDX) Stock Down 14% Today?
Lucira Health (NASDAQ: LHDX ) stock is falling on Friday after the company's shares have seen extreme volatility throughout the week. That includes a massive rally earlier this week that saw the company's shares gain as much as 871% since its closing price on Friday.» Mehr auf investorplace.com
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its combination at-home COVID-19 and a flu test. The over-the-counter (OTC) 30-minute at-home rapid test can detect influenza A and B and the SARS-CoV-2 virus using nasal swabs.» Mehr auf marketbeat.com
Penny Stocks: The Importance of Liquidity and Volume
Using liquidity and volume to make money with penny stocks The post Penny Stocks: The Importance of Liquidity and Volume appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.» Mehr auf pennystocks.com
Unternehmenszahlen
| (EUR) | 2021 | |
|---|---|---|
| Umsatz | 81,83 Mio | 36.948,81% |
| Bruttoeinkommen | 8,99 Mio | 754,89% |
| Nettoeinkommen | −57,01 Mio | 85,63% |
| EBITDA | −53,52 Mio | 120,93% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 16,18 Mio€ |
Anzahl Aktien | 40,60 Mio |
52 Wochen-Hoch/Tief | 3,83€ - 0,0951€ |
| Dividenden | Nein |
Beta | 3,76 |
KGV (PE Ratio) | −0,24 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | 0,08 |
KUV (PS Ratio) | 0,20 |
Unternehmensprofil
| Name | Lucira Health Inc |
| CEO | Erik T. Engelson |
| Mitarbeiter | 221 |
Assets entdecken
Shareholder von Lucira Health Inc investieren auch in folgende Assets
